Extracellular Proteases Scholarly Peer-review Journal
One of the key targets of
drug development is proteases. Extracellular proteases are a complex and heterogeneous enzyme family that carries many important biological functions. This review explores the vasculature-related extracellular proteases, their roles and how protease disorders can lead to plaque formation, including chronic atherosclerosis, acute coronary syndromes, restenosis, and vascular remodelling. Extracellular proteases (ECPs) in many pathophysiological processes, including cancer,
cardiovascular disorders, and inflammatory, pulmonary, and parodontal diseases, due to their differential expression. Several new ECP inhibitors are currently under clinical review and a significant rise in new protease inhibition-based therapies can be predicted in the coming years. Beyond directly blocking a specific protease function, differential expression in disease states may be used to deliver therapeutic or imaging agents selectively.
High Impact List of Articles
-
Anti-Anxiety Effects of Mercurialis annua Aqueous Extract in the Elevated Plus Maze Test.
Zouhra Doukkali, Rabie Kamal, Meryem El Jemelif, Mohamed Nadjmouddine, Amina Zellou, Yahya Cherrah, Katim Alaoui and Khalid Taghzouti
Research Article: Pharmaceutical Bioprocessing
-
Anti-Anxiety Effects of Mercurialis annua Aqueous Extract in the Elevated Plus Maze Test.
Zouhra Doukkali, Rabie Kamal, Meryem El Jemelif, Mohamed Nadjmouddine, Amina Zellou, Yahya Cherrah, Katim Alaoui and Khalid Taghzouti
Research Article: Pharmaceutical Bioprocessing
-
Bioprocess engineering: micromanaging Chinese hamster ovary cell phenotypes
Paul S Kelly, Colin Clarke, Martin Clynes and Niall Barron*
Review Article: Pharmaceutical Bioprocessing
-
Bioprocess engineering: micromanaging Chinese hamster ovary cell phenotypes
Paul S Kelly, Colin Clarke, Martin Clynes and Niall Barron*
Review Article: Pharmaceutical Bioprocessing
-
Molecular pharming in plants and plant cell cultures: a great future ahead?
Anneli Ritala*, Suvi T Hakkinen and Stefan Schillberg
Commentary: Pharmaceutical Bioprocessing
-
Molecular pharming in plants and plant cell cultures: a great future ahead?
Anneli Ritala*, Suvi T Hakkinen and Stefan Schillberg
Commentary: Pharmaceutical Bioprocessing
-
In situ microscopy and MIR-spectroscopy as non-invasive optical sensors for cell cultivation process monitoring
Christian Luder, Patrick Lindner, David Bulnes-Abundis, Shaobin M Lu, Tim Lucking, Dorte Solle* and Thomas Scheper
Research Article: Pharmaceutical Bioprocessing
-
In situ microscopy and MIR-spectroscopy as non-invasive optical sensors for cell cultivation process monitoring
Christian Luder, Patrick Lindner, David Bulnes-Abundis, Shaobin M Lu, Tim Lucking, Dorte Solle* and Thomas Scheper
Research Article: Pharmaceutical Bioprocessing
-
Antifoams: the overlooked additive?
Sarah J Routledge*, David R Poyner and Roslyn M Bill
Editorial: Pharmaceutical Bioprocessing
-
Antifoams: the overlooked additive?
Sarah J Routledge*, David R Poyner and Roslyn M Bill
Editorial: Pharmaceutical Bioprocessing
Relevant Topics in Clinical